A Real-world Study Cohort of Postmenopausal Women With Osteoporosis Taking Zoledronic Acid or Oral Bisphosphonates.
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2016
At a glance
- Drugs Bisphosphonates; Zoledronic acid
- Indications Fracture; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms IVORY
- Sponsors Novartis Pharmaceuticals
- 03 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Apr 2012 Planned End Date changed from 1 Dec 2014 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 20 Sep 2011 Interim 1-year results presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History